Prevention and management of meconium aspiration syndrome--assessment of evidence based practice.
Greenough
Anne
A
Division of Asthma, Allergy and Lung Biology, Department of Child Health, 4th Floor Golden Jubilee Wing, King's College Hospital, Denmark Hill, SE5 9RS London, UK . anne.greenough@kcl.ac.uk
Pulikot
Ashok
A
Dimitriou
Gabriel
G
D000653:Amniotic Fluid; D018893:Bronchoalveolar Lavage / Q000706:statistics & numerical data; D001993:Bronchodilator Agents / Q000627:therapeutic use; D011464:Epoprostenol / Q000627:therapeutic use; D015199:Extracorporeal Membrane Oxygenation / Q000706:statistics & numerical data; D006801:Humans; D007231:Infant, Newborn; D007263:Infusions, Parenteral / Q000706:statistics & numerical data; D008278:Magnesium Sulfate / Q000627:therapeutic use; D008471:Meconium Aspiration Syndrome / Q000628:therapy*; D009569:Nitric Oxide / Q000627:therapeutic use; D009960:Oropharynx; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011663:Pulmonary Surfactants / Q000627:therapeutic use; D012121:Respiration, Artificial / Q000706:statistics & numerical data; D012965:Sodium Chloride / Q000008:administration & dosage; D013396:Suction / Q000706:statistics & numerical data; D011795:Surveys and Questionnaires; D013577:Syndrome; D014043:Tolazoline / Q000627:therapeutic use; D014132:Trachea; D006113:United Kingdom; D014665:Vasodilator Agents / Q000627:therapeutic use
D001993:Bronchodilator Agents; D011663:Pulmonary Surfactants; D014665:Vasodilator Agents; D009569:Nitric Oxide; D012965:Sodium Chloride; D008278:Magnesium Sulfate; D014043:Tolazoline; D011464:Epoprostenol
Cochrane Database Syst Rev. 2000;(2):CD000500
10796213
Pediatrics. 1990 May;85(5):715-21
2330231
J Pediatr. 1994 Mar;124(3):447-54
8120720
Lancet. 1996 Jul 13;348(9020):75-82
8676720